$FLEX

McSweeney Erin sold $265K of FLEX

McSweeney Erin sold 2,000 shares of FLEX LTD. (FLEX) at $132.51 ($0.27M total) on 2026-05-22.

Original reporting
SEC EDGAR · McSweeney Erin
Published May 27, 2026, 12:22 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 27, 2026, 12:31 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$FLEX
Bearish
medium confidence
Mentioned
$FLEX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FLEXBearishLow
01

Why it matters

Because it is a director open-market sale and explicitly notes no 10b5-1 plan, traders may treat it as a modest bearish signal; however, there is no accompanying operational/financial catalyst in the article.

02

Market read

Use as a sentiment/positioning input rather than a standalone fundamental catalyst.

03

What to watch

The filing lacks stated rationale; also only one transaction is shown, so trend assessment (future Form 4s) matters more than this single sale.

Relevance 6/10Timing: Immediate/near-term sentiment read; effect typically fades unless repeated or accompanied by other signals.

Background

The article is an SEC insider transaction disclosure (Form 4) for FLEX, filed 2026-05-26, covering a sale executed 2026-05-22.

Company-level read

Ticker impact

$FLEXBearishMedium confidence
Context

SEC Form 4 shows director Erin McSweeney sold 2,000 FLEX shares in an open-market transaction on 2026-05-22.

Expected impact

Likely limited near-term impact; watch for follow-through selling or unusual volume rather than a directional catalyst.

Evidence & confidence

The filing is a disclosed insider sale (not a buy) and explicitly states no pre-arranged 10b5-1 plan, which can increase interpretive sensitivity, but the article provides no fundamental company news.

Market effects

No sector-wide read-through; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Director sales can be routine (tax/liquidity/diversification) and the absence of a 10b5-1 plan does not necessarily imply negative fundamentals.

Key entities

  • FLEX LTD.

    Company whose director insider sale is disclosed via SEC Form 4.

  • Erin McSweeney

    Director who sold 2,000 shares of FLEX on 2026-05-22.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FLEXHighAI 9/10

Why is Flex stock surging today?

Flex (FLEX) stock rose 8.6% pre-market after Q2 2027 earnings beat estimates, with EPS at $1.18 vs. $1.06 and revenue at $8.5B vs. $8.17B. Management raised FY2027 guidance, and BofA reiterated a Buy rating. The stock had previously fallen below its 52-week high of $166.86.

$FLEXMedAI 9/10

Flex earnings beat by $0.12, revenue topped estimates

Flex reported Q2 EPS of $1.18, beating estimates by $0.12, with revenue at $8.5B, exceeding expectations. The company forecasted FY 2027 EPS of $4.84-$5.16 and revenue of $34.90B-$35.90B. Shares are down 26.73% over 3 months but up 26.10% year-over-year, with a 'fair performance' financial health score.

$FLEXHighAI 9/10

FLEX REPORTS SECOND QUARTER FISCAL 2027 RESULTS

FLEX LTD. (FLEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. P R E S S R E L E A S E EXHIBIT 99.1 FLEX REPORTS SECOND QUARTER FISCAL 2027 RESULTS • Reported Q2 net sales of $8.5 billion, up 25% versus the prior year. • Delivered Q2 GAAP operating margin of 4.9%, and adjusted operating margin of 7.1%. • Reported Q2 GAAP EPS of $0.70, and re

$FLEXMedAI 8/10

FLEX REPORTS SECOND QUARTER FISCAL 2027 RESULTS

Flex reported Q2 2027 net sales of $8.5B, up 25% YoY. GAAP EPS was $0.70, adjusted EPS $1.18. CEO Revathi Advaithi highlighted growth and a planned spin-off. Q3 guidance: sales $8.87B-$9.17B, adjusted EPS $1.19-$1.25. FY2027 guidance updated to sales $34.9B-$35.9B, adjusted EPS $4.84-$5.16.